Biocon shares jump 8% post Q4 results. Is the Street happy?

May 24, 2023

Biocon’s shares surged by 8% on Tuesday due to strong Q4 earnings growth. Net profit grew by 31% to INR 313 crore with 57% YoY growth in consolidated revenue from operations totaling INR 3,774 crore. Operating profit EBITDA surged 75% while gross spending on R&D rose by 53% to INR 356 crore. The biosimilars business stood out with revenue more than doubling on YoY basis to INR 2,102 crore. However, despite strong results, Biocon reportedly missed estimates, according to Motilal Oswal.

More To Explore

Suryoday Small Finance Bank Q3 Results: Profit slumps 42% to Rs 33 crore

Suryoday Small Finance Bank reported a 42% YoY drop in Q3 FY25 net profit to ₹33.3 crore due to higher expenses and worsening asset quality,

January 23, 2025

MMT posts a profit of $27 million in Q3, revenue at $ 267.4 million

MakeMyTrip posted a Q3 FY25 profit of $27M, up from $24M last year, with revenues rising 26.2% to $267.4M. Strong growth in gross bookings, international

January 23, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003